Jukes,
Thanks again.
These guys need to be kept on their toes in relation to targets in their presentations.
For a while under Life Therapeutics they had some good forecasting but it all started to go wrong when they got into blood fractionation and started to ramp up their USA operation and added a lot of extra 'chiefs' to the head count.
Lets hope they have learnt from their lessons there and have a more focused approach to the development in SE Asia (and hopefully elsewhere).
As I understand, costing was the big issue.
The ramp p forecasts of the SpermSep is another issue that needs to be monitored.
Here's to a successful 2011.
Regards
Jukes,Thanks again.These guys need to be kept on their toes in...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $1.96K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 4699999 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 7039269 | 5 |
View Market Depth
| Last trade - 15.58pm 15/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
